pharmaphorum January 23, 2020
Paul Tunnah sat down with Livongo’s CEO Zane Burke to discuss how he has applied lessons from bigger companies in his new role and his thoughts on health tech’s relationship with patients and pharma.
When influential US pharmacy benefit company Express Scripts announced the digital apps that had made it into its first ever formulary for digital therapeutics, health monitoring and insights firm Livongo took centre stage as the preferred choice in three product categories.
The company’s technology offers clinically based insights to users to help them stay healthy, in particular by offering personalised health signals to users. Its Livongo Health for diabetes, pre-diabetes, and hypertension were all named as preferred options in their categories,
Express Scripts’ nod is especially...